Overview

At Flora Growth Corp. (Flora), we are building the world’s largest and lowest cost vertically-integrated producer of organic cannabis and pharmaceutical-grade medical products as well as OTC CBD-based consumer products.

You Are Not Investing in An Idea

We are developing a business looking to generate revenue in 2020.

To achieve this objective, we have worked tirelessly and developed a strategy that will allow us to make a great difference and generate revenue in the short term.

 

How are we going to do it?

PRODUCT DEVELOPMENT AND LOW PRODUCTION COST

We will control the largest non-psychoactive organic crop of cannabis in the world. This allows us to produce at an expected cost of US$0.18 per gram. If we were to sell our products at the same average price in the US today, we would have a profit margin of nearly 800% (or around 700% in Canada).

 

KEY ACQUISITIONS, UNIQUE BRANDS

We have signed letters of intent to acquire two companies, Cronomed and Mambe, which will allow us to ensure vertical growth and near-term revenue generation. Flora’s beauty and cosmetics division, “Flora Beauty”, will produce nine different beauty and cosmetic products via a high-end product line called “Mind” and a mass-market product line called “Elements” using Flora’s own organic CBD oil.
 

 

 

GLOBALLY SIGNIFICANT WITH HIGH QUALITY PRODUCTS

We expect to supply the worldwide pharmaceutical, cosmetic industries with the highest-quality CBD oils and derivatives in the market.